🇺🇸 Nicotine patches in United States

36 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 7 reports (19.44%)
  2. Headache — 5 reports (13.89%)
  3. Insomnia — 4 reports (11.11%)
  4. Asthenia — 3 reports (8.33%)
  5. Chest Pain — 3 reports (8.33%)
  6. Chromaturia — 3 reports (8.33%)
  7. Dizziness — 3 reports (8.33%)
  8. Fall — 3 reports (8.33%)
  9. Nausea — 3 reports (8.33%)
  10. Anaemia — 2 reports (5.56%)

Source database →

Other Addiction Medicine / Smoking Cessation approved in United States

Frequently asked questions

Is Nicotine patches approved in United States?

Nicotine patches does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Nicotine patches in United States?

University of California, San Francisco is the originator. The local marketing authorisation holder may differ — check the official source linked above.